Log In
BCIQ
Print this Print this
 

Relipoietin, erythropoietin (EPO) (Epostim)

  Manage Alerts
Collapse Summary General Information
Company Reliance GeneMedix plc
DescriptionErythropoiesis stimulating agent (ESA)
Molecular Target Erythropoietin (EPO) receptor
Mechanism of ActionErythropoietin (EPO) receptor agonist
Therapeutic ModalityBiologic: Protein
Latest Stage of DevelopmentMarketed
Standard IndicationAnemia
Indication DetailsTreat anemia; Treat anemia associated with chemotherapy; Treat anemia associated with chronic renal failure (CRF); Treat anemia in zidovudine-treated HIV patients
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today